prescription drug monitoring programmes

Impact of Florida’s prescription drug monitoring program on drug- related fatal vehicle crashes: a difference-in-differences approach
Moosa Tatar, Mohammad S. Jalali, Hyo Jung Tak, Li-Wu Chen, Ozgur M. Araz, Fernando A. Wilson

Injury Prevention Apr 2022, 28 (2) 105-109; DOI: 10.1136/injuryprev-2020-044113

CLINICAL
- Evidence based practice
- Paediatrics
  - Preventative pediatrics
- Sports and exercise medicine
  - Physical injuries
  - Procedures
NON-CLINICAL
- Epidemiology
  - Clinical trials (epidemiology) (141)
  - Epidemiologic studies (966)
  - Population trends
  - Screening (epidemiology)
  - Survey techniques (4)
  - Therapeutic trials
  - Time-to-event methods (2)
- Occupational and environmental medicine
  - Disease and health outcomes
    - Accidents, injuries (6)
    - Injuries, accidents (6)
- Public health
  - Abuse (child, partner, elder) (81)
  - Accidents
  - Injury diagnoses
    - Burns (diagnoses) (6)
    - Fractures (55)
    - Head injury (7)
    - Spinal cord injury (15)
  - Injury location
    - Workplace injury (9)
  - Injury mechanisms
    - ATV motorcycle injury
    - Burns (6)
    - Cyclist injury
    - Drowning (181)
    - Falls injury
    - Motor vehicle (non traffic) injury
    - Occupational injury
    - Pedestrian injury
    - Poisoning/Injestion (163)
    - Recreation/Sports injury (37)
    - Road traffic (occupant) injury
    - Suffocation
    - Suicide/Self harm (injury) (232)
    - Violence (102)
  - Suicide (public health) (232)
  - Violence (other)
  - Violence against women (102)
- Statistics and research methods
  - Qualitative research
  - Quantitative research
Special collections
- Editor's choice (56)
- Guidelines, Recommendations and Consensus Statements
- IP Cochrane corners (27)
- IP Gun violence (50)
- IP Methodologic issues (1)
- Open access (122)
- Press releases (63)

Log in using your username and password

Main menu

Log in using your username and password

You are here

prescription drug monitoring programmes